RIFAXIMIN PLUS LACTULOSE IS MORE EFFICACIOUS THAN LACTULOSE ALONE FOR THE PREVENTION OF OVERT HEPATIC ENCEPHALOPATHY (OHE) IN PATIENTS WITH OR WITHOUT ASCITES

被引:0
|
作者
Kowdley, Kris V.
Reau, Nancy
Pyrsopoulos, Nikolaos T.
Allen, Christopher
Heimanson, Zeev
Sanyal, Arun J.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1548
引用
收藏
页码:S1327 / S1327
页数:1
相关论文
共 50 条
  • [1] Rifaximin plus lactulose is more effective than lactulose alone for the prevention of overt hepatic encephalopathy in patients with or without diabetes
    Bajaj, Jasmohan S.
    Wong, Robert
    Heimanson, Zeev
    Allen, Christopher
    Israel, Robert
    Sanyal, Arun
    JOURNAL OF HEPATOLOGY, 2023, 78 : S236 - S236
  • [2] Rifaximin Plus Lactulose Is More Efficacious Than Lactulose Alone for Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence: A Subgroup Analysis by Viral or Alcohol Cirrhosis Etiology
    Bajaj, Jasmohan
    Sanyal, Arun
    Sundaram, Vinay
    Frenette, Catherine
    Heimanson, Zeev
    Israel, Robert
    Brown, Robert S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S570 - S570
  • [3] OUTCOMES OF RIFAXIMIN PLUS LACTULOSE VERSUS LACTULOSE ALONE IN TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY
    Gill, M. L.
    Niaz, T.
    Aziz, H.
    Khan, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S215 - S215
  • [4] RIFAXIMIN PLUS LACTULOSE IS MORE EFFICACIOUS THAN LACTULOSE ALONE FOR RISK REDUCTION OF OVERT HEPATIC ENCEPHALOPATHY RECURRENCE: A SUBGROUP ANALYSIS BY VIRAL OR ALCOHOL CIRRHOSIS ETIOLOGY
    Bajaj, Jasmohan S.
    Sanyal, Arun J.
    Sundaram, Vinay
    Frenette, Catherine T.
    Heimanson, Zeev
    Israel, Robert J.
    Brown, Robert S.
    GASTROENTEROLOGY, 2022, 162 (07) : S1176 - S1176
  • [5] Is Lactulose Plus Rifaximin Better than Lactulose Alone in the Management of Hepatic Encephalopathy?
    Butt, Nauman Ismat
    Butt, Usman Ismat
    Kakar, Aniqa Anser Tufail Khan
    Malik, Tashia
    Siddiqui, Arif Mahmood
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (02): : 115 - 117
  • [6] Hepatic Encephalopathy - Lactulose plus Rifaximin more effective than Monotherapy
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (01): : 9 - 9
  • [7] RIFAXIMIN PLUS LACTULOSE VERSUS LACTULOSE ALONE FOR REDUCING THE RISK OF OVERT HEPATIC ENCEPHALOPATHY RECURRENCE: A POOLED SUBGROUP ANALYSIS
    Sanyal, Arun J.
    Brown, Robert S., Jr.
    Sundaram, Vinay
    Heimanson, Zeev
    Israel, Robert J.
    Bajaj, Jasmohan S.
    HEPATOLOGY, 2022, 76 : S1186 - S1187
  • [8] A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
    Sharma, Barjesh Chander
    Sharma, Praveen
    Lunia, Manish Kumar
    Srivastava, Siddharth
    Goyal, Rohit
    Sarin, S. K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (09): : 1458 - 1463
  • [9] RIFAXIMIN AND LACTULOSE COMBINATION THERAPY VERSUS LACTULOSE ALONE FOR PREVENTION OF OVERT HEPATIC ENCEPHALOPATHY RECURRENCE: A POOLED ANALYSIS OF TWO RANDOMIZED TRIALS
    Bajaj, Jasmohan S.
    Heimanson, Zeev
    Israel, Robert
    GASTROENTEROLOGY, 2019, 156 (06) : S560 - S560
  • [10] Impact of Rifaximin Monotherapy Versus Rifaximin and Lactulose Combination Therapy on Quality of Life in Patients With a History of Overt Hepatic Encephalopathy (OHE)
    Sanyal, Arun J.
    Heimanson, Zeev
    Israel, Robert
    Mullen, Kevin D.
    Flamm, Steven L.
    HEPATOLOGY, 2017, 66 : 268A - 268A